7 results
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... Pathophysiology ... Treatment: • Plasmapheresis ... Syndrome #diagnosis #management ... #treatment #neurology
Pharmacotherapy for Migraine Prophylaxis 

Who is indicated for migraine prophylaxis? Patients who experience more than 3
appropriate acute treatment ... Medications #Table #Pharmacology ... #Management #Neurology ... #PrimaryCare
Clinic, Home, and Ambulatory Blood Pressure Measurements - Strengths and Weaknesses
(via https://twitter.com/JACCJournals/status/1088104323354185730 )

Clinic Measurements:
• BP measured
used to guide treatment ... the accuracy of readings ... the floor • BP readings ... Home #Ambulatory #Management ... #PrimaryCare #Comparison
Migraine Treatment Overview

 • What is a Migraine?
 • Pathophysiology
 • Common Migraine Triggers
 • Diagnosis
Migraine Treatment ... • Pathophysiology ... Prophylactic Treatment ... #management #pharmacology ... #prophylaxis #neurology
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Disease, PRES Pathophysiology ... inflammation, leading ... Erythematosus #SLE #CNS #neurology ... cerebritis #diagnosis #management ... #treatment
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... the underlying pathophysiology ... and cauda equina TREATMENT ... Syndrome #diagnosis #management ... #neurology
Potassium Binders for Management of Hyperkalemia
 • SPS - Sodium polystyrene sulfonate
 • Patiromer (veltassa)
 •
Potassium Binders for Management ... #Hyperkalemia #treatment ... #pharmacology # ... table #comparison ... #nephrology